Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation

被引:83
作者
Cairo, Mitchell S. [1 ,2 ,3 ,4 ,5 ]
Cooke, Kenneth R. [6 ]
Lazarus, Hillard M. [7 ]
Chao, Nelson [8 ,9 ,10 ]
机构
[1] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA
[5] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
[7] Case Western Reserve Univ, Dept Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[8] Duke Univ, Dept Med, Durham, NC USA
[9] Duke Univ, Dept Immunol, Durham, NC USA
[10] Duke Univ, Dept Pathol, Durham, NC 27706 USA
关键词
sinusoidal obstruction syndrome; veno-occlusive disease; haematopoietic cell transplantation; definitions; grading; BONE-MARROW-TRANSPLANTATION; SEVERE VENOOCCLUSIVE DISEASE; SYNDROME/VENO-OCCLUSIVE DISEASE; SINUSOIDAL OBSTRUCTION SYNDROME; RISK-FACTORS; ENDOTHELIAL-CELLS; EUROPEAN-SOCIETY; LIVER-DISEASE; ALLOGENEIC TRANSPLANTATION; SIGNIFICANT TOXICITY;
D O I
10.1111/bjh.16557
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno-occlusive disease (VOD), remains a multi-organ system complication following haematopoietic cell transplantation (HCT). When SOS/VOD is accompanied by multi-organ dysfunction, overall mortality rates remain >80%. However, the definitions related to the diagnosis and grading of SOS/VOD after HCT are almost 25 years old and require new and contemporary modifications. Importantly, the pathophysiology of SOS/VOD, including the contribution of dysregulated inflammatory and coagulation cascades as well as the critical importance of liver and vascular derived endothelial dysfunction, have been elucidated. Here we summarise new information on pathogenesis of SOS/VOD; identify modifiable and unmodifiable risk factors for disease development; propose novel, contemporary and panel opinion-based diagnostic criteria and an innovative organ-based method of SOS/VOD grading classification; and review current approaches for prophylaxis and treatment of SOS/VOD. This review will hopefully illuminate pathways responsible for drug-induced liver injury and manifestations of disease, sharpen awareness of risk for disease development and enhance the timely and correct diagnosis of SOS/VOD postHCT.
引用
收藏
页码:822 / 836
页数:15
相关论文
共 104 条
[1]
Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation [J].
Akil, Ayman ;
Zhang, Qing ;
Mumaw, Christen L. ;
Raiker, Nisha ;
Yu, Jeffrey ;
de Mendizabal, Nieves Velez ;
Haneline, Laura S. ;
Robertson, Kent A. ;
Skiles, Jodi ;
Diaz-Ricart, Maribel ;
Carreras, Enric ;
Renbarger, Jamie ;
Hanash, Samir ;
Bies, Robert R. ;
Paczesny, Sophie .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (10) :1739-1745
[2]
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors [J].
Ando, Minoru ;
Ohashi, Kazuteru ;
Akiyama, Hideki ;
Sakamaki, Hisashi ;
Morito, Taku ;
Tsuchiya, Ken ;
Nitta, Kosaku .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (01) :278-282
[3]
Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis [J].
Armand, Philippe ;
Kim, Haesook T. ;
Virtanen, Johanna M. ;
Parkkola, Riitta K. ;
Itala-Remes, Maija A. ;
Majhail, Navneet S. ;
Burns, Linda J. ;
DeFor, Todd ;
Trottier, Bryan ;
Platzbecker, Uwe ;
Antin, Joseph H. ;
Wermke, Martin .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) :1248-1251
[4]
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes [J].
Artz, Andrew S. ;
Logan, Brent ;
Zhu, Xiaochun ;
Akpek, Gorgun ;
Martino Bufarull, Rodrigo ;
Gupta, Vikas ;
Lazarus, Hillard M. ;
Litzow, Mark ;
Loren, Alison ;
Majhail, Navneet S. ;
Maziarz, Ric Hard T. ;
McCarthy, Philip ;
Popat, Uday ;
Saber, Wael ;
Spellman, Stephen ;
Ringden, Olle ;
Wickrema, Amittha ;
Pasquini, Marcelo C. ;
Cooke, Kenneth R. .
HAEMATOLOGICA, 2016, 101 (11) :1426-1433
[5]
ATTAL M, 1992, BLOOD, V79, P2834
[6]
THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[7]
VENOOCCLUSIVE DISEASE OF THE LIVER - DEVELOPMENT OF A MODEL FOR PREDICTING FATAL OUTCOME AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI ;
ANDERSON, GL ;
MORI, M ;
HINDS, MS ;
SHULMAN, HM ;
MCDONALD, GB .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1729-1736
[8]
BRAS G, 1954, AMA ARCH PATHOL, V57, P285
[9]
Tumour lysis syndrome: new therapeutic strategies and classification [J].
Cairo, MS ;
Bishop, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (01) :3-11
[10]
The role of the endothelium in the short-term complications of hematopoietic SCT [J].
Carreras, E. ;
Diaz-Ricart, M. .
BONE MARROW TRANSPLANTATION, 2011, 46 (12) :1495-1502